Clinical trial Recruiting at 1 site Interventional Ages 18 to 55

Using mild electrical brain stimulation plus DBT skills training for adults with ADHD

Official title: Effects and Mechanisms of Transcranial Direct Current Stimulation Combined With Dialectical Behavior Therapy Skills Training in Adults With Attention-Deficit/Hyperactivity Disorder

Run by Nanjing Medical University · NCT07565402 · Data updated 2026-11-12

This trial will try adding mild electrical brain stimulation (tDCS) to DBT skills training to see if it helps adults with ADHD improve attention, impulse control, and daily functioning.

Quick facts

Study typeInterventional
Ages18 Years to 55 Years
SexAll
Enrollment60 (estimated)
SponsorNanjing Medical University
Academic / other
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedApril 1, 2026
Main results expectedJune 21, 2028
Study endsSeptember 1, 2028
Registry record updatedMay 4, 2026
Trial IDNCT07565402 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–55 years old with a DSM-5 diagnosis of ADHD confirmed by DIVA-5, who are right-handed, medically stable, willing to attend in-person sessions, and able to give informed consent are the ideal candidates.

Probably not a fit

Individuals with other neurological or psychiatric disorders, intracranial metal or electronic implants, recent ECT, pregnancy or breastfeeding, planned ADHD medication changes, or who are not right-handed may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study delivers transcranial direct current stimulation (tDCS) alongside Dialectical Behavior Therapy Skills Training (DBT-ST) to right-handed adults aged 18–55 who meet DSM-5 criteria for ADHD as confirmed by the Chinese DIVA-5 diagnostic interview. Participants with neurological or other psychiatric disorders, cranial implants, recent ECT, pregnancy/breastfeeding, severe physical illness, or planned medication changes are excluded. Clinical symptom measures and executive-function tests, and possibly neurophysiological markers, are used to track outcomes and examine mechanisms. Treatment sessions and follow-ups are conducted on site at Nanjing Brain Hospital.

Why it matters

Potential benefit: If successful, the combined approach could improve attention, impulse control, and everyday functioning more than DBT skills training alone.

How similar studies have gone: Separate small studies have reported modest benefits from tDCS on cognition and from DBT-ST on emotion and behavior, but combining these interventions for adult ADHD is relatively novel and has limited prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Meet the diagnostic criteria for attention-deficit/hyperactivity disorder (ADHD) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Diagnosis confirmed using the Chinese version of the Diagnostic Interview for ADHD in Adults (DIVA-5).
* Aged between 18 and 55 years.
* Right-handed.
* Voluntary participation with provision of written informed consent.

Exclusion Criteria:

* Presence of neurological disorders or other psychiatric disorders.
* Severe physical illness.
* Receipt of electroconvulsive therapy (ECT) or other physical treatments within 6 months prior to enrollment.
* Planned changes in ADHD-related medication before the final follow-up assessment.
* Contraindications to tDCS (e.g., intracranial metal or electronic implants, skull plates, or other cranial implants).
* Pregnancy or breastfeeding.

Where it's running

  • Nanjing Brain Hospital
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.